Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...

Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, ...

Let's consider these excellent candidates: CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals (NASDAQ: VRTX), two innovative drugmakers. Here's why they are both buys heading into 2026.

As of Friday, December 12, Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 32.45%, which has investors questioning ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...

Gene-edited goldenberries clear USDA review, moving closer to farms. Compact plants solve farming challenges for this ...

In a study published in Genome Research, a team of researchers, including Cornell College Assistant Professor of Biology ...

Watson’s biohacker friend Hobie—also known as the man with the glowing chest—returns when a risky gene-editing experiment ...

GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...

Trump’s food price probe, research on what really drives acceptance of gene-edited foods and KeHE’s latest read on ...

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of ...

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...